Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Corcept Therapeutics Incorporated.
Corcept Therapeutics Incorporated business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Corcept Therapeutics Incorporated are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Corcept Therapeutics Incorporated , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Corcept Therapeutics Incorporated including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Corcept Therapeutics Incorporated and all latest updates of the company are provided.
The 2025 version of Corcept Therapeutics Incorporated report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Corcept Therapeutics Incorporated- Key Facts
2.2 Corcept Therapeutics Incorporated- Geographic Locations
2.3 Corcept Therapeutics Incorporated- Subsidiaries and Affiliates
2.4 Corcept Therapeutics Incorporated- Business Divisions
2.5 Corcept Therapeutics Incorporated- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Corcept Therapeutics Incorporated Strategic Analysis Review
3.1 Corcept Therapeutics Incorporated- Key Strategies
3.2 Corcept Therapeutics Incorporated- Company Outlook Statement
3.3 Corcept Therapeutics Incorporated- SWOT Analysis
3.3.1 Corcept Therapeutics Incorporated- Key Strengths
3.3.2 Corcept Therapeutics Incorporated- Key Weaknesses
3.3.3 Corcept Therapeutics Incorporated- Potential Opportunities
3.3.4 Corcept Therapeutics Incorporated- Potential Threats
3.4 Corcept Therapeutics Incorporated- Key Competitors
4. Business Description of the Company
4.1 Corcept Therapeutics Incorporated- Business Overview
4.2 Corcept Therapeutics Incorporated- Operations by Segment
5 Products and Services Details
5.1 Corcept Therapeutics Incorporated- Key Products
5.2 Corcept Therapeutics Incorporated- Key Service Areas
5.3 Corcept Therapeutics Incorporated- Key Brands
6 Company Developments
6.1 Corcept Therapeutics Incorporated- Company History
6.2 Corcept Therapeutics Incorporated- Latest Developments
7 Financial Analysis
7.1 Corcept Therapeutics Incorporated- Income Statements
7.2 Corcept Therapeutics Incorporated- Balance Sheet
7.3 Corcept Therapeutics Incorporated- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Corcept Therapeutics Incorporated- Direct Competitors
8.2 Corcept Therapeutics Incorporated- Competitor Financial Ratios comparison
8.3 Corcept Therapeutics Incorporated- Competitor Stock Charts Comparison
8.4 Corcept Therapeutics Incorporated- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!